Precise blood sugar control without compromise—Tragliptin succinate tablets help achieve stable blood sugar levels.
Share
When blood sugar fluctuates like a roller coaster, precise blood sugar control becomes the ultimate goal of diabetes management . Trelagliptin succinate tablets achieve all-day intelligent blood sugar protection through a unique "glucose-dependent hypoglycemic mechanism," making it possible to steadily achieve the target level of glycated hemoglobin (HbA1c).
01 The Silent Killer of Blood Sugar Fluctuations: More Dangerous Than High Blood Sugar
Three deadly dangers of blood sugar drift
|
Hazard types |
Mechanism of occurrence |
Clinical consequences |
|
Endothelial injury |
Drastic fluctuations in blood sugar → Increased oxidative stress |
Accelerated atherosclerosis |
|
Neuropathy |
Sorbitol pathway activation → neuronal edema |
numbness/pain in hands and feet |
|
Hypoglycemic rebound |
Hypoglycemia → Glucose-raising hormone surge → Reactive hyperglycemia |
Increased risk of cardiovascular events |
Shocking data :
● Patients with daily blood glucose fluctuations >4.4 mmol/L have a 3.2-fold increased risk of cardiovascular death.
● For every 2 mmol/L increase in postprandial blood glucose peak, the risk of retinopathy increases by 18%.
02 The Dilemma of Traditional Hypoglycemic Drugs in Blood Sugar Control
The unavoidable trap of blood sugar fluctuations
Insulin/sulfonylurea drugs :
Overstimulation of insulin secretion
→ Blood sugar drops sharply 2 hours after a meal
→ Rebound increase before the next meal
→ Forming a "sawtooth" blood sugar curve
α-Glucosidase inhibitors (such as acarbose) :
Although it can lower postprandial blood glucose, it is ineffective in regulating fasting blood glucose , and gastrointestinal side effects cause 30% of patients to discontinue the medication.
03 Trelagliptin: A revolutionary breakthrough in precise blood sugar control
The biological code of intelligent blood sugar reduction
Mechanism of action :
✅ Selective inhibition of DPP-4 enzyme
→ Increase active GLP-1 levels (physiological incretin)
→ Glucose-dependent insulin secretion (activated only when blood glucose > 5.6 mmol/L)
→ Simultaneously inhibit glucagon (block excessive hepatic glucose output).
Three key characteristics of precision medicine :
|
characteristic |
Implementation principle |
Clinical value |
|
Effective on demand |
The higher the blood sugar, the stronger the secretion-stimulating effect. |
Avoid hypoglycemia (hypoglycemia rate with single-drug therapy <0.1%). |
|
24-hour coverage |
Half-life 50 hours, DPP-4 inhibition rate >70%/7 days |
Both fasting and postprandial blood glucose levels reached the target. |
|
Gastrointestinal friendly |
Does not stimulate gastrointestinal motility |
The incidence of diarrhea is only 1.2% (compared to 30% for metformin). |
Key data :
● It can reduce HbA1c by 0.8%-1.2% (monotherapy for 24 weeks).
● Daily blood glucose fluctuations decreased by 42% (compared to glimepiride)
04 Four-Dimensional Blood Sugar Control Strategy: Making Your Blood Sugar Curve Smooth Like a Mirror
Dimension 1: Precision Drug Combination Therapy
The perfect pairing :
|
Combined solution |
Complementary mechanisms of action |
HbA1c decrease increased |
|
Treglitazone + Metformin |
Improve insulin resistance + enhance incretin effect |
+0.4% -0.6% |
|
Trelagliptin + SGLT2 inhibitor |
Glycosamine elimination for weight loss + DPP-4 inhibition |
+0.3%-0.5% |
Dimension 2: Protein temporal control method
The Protein Revolution in Breakfast :
Consume 20-30g of high-quality protein within 30 minutes of waking up (such as 3 egg whites + unsweetened soy milk).
→ Activates GLP-1 secretion, enhancing trelagliptin sensitivity
→ Postprandial blood glucose peak decreased by 1.8-2.2 mmol/L
Dimension 3: Resistance Exercise for Lowering Blood Sugar
Muscle activation twice daily :
● Before breakfast: 3 x 15 reps of resistance band squats (to increase muscle glucose uptake)
● After dinner: Perform wall squats for 90 seconds x 3 sets (to reduce nighttime blood sugar fluctuations)
Dimension 4: Dynamic Monitoring and Optimization
Key indicators of CGM (Continuous Glucose Monitoring) :
● TIR (Time to Target Blood Glucose Level) Target > 70%
● GV (Glycemic Variance) Target < 36%
05 Real-world case study: From blood sugar rollercoaster to steady plateau
Mr. Chen, 58 years old, has had the disease for 8 years.
● Original treatment : Glimepiride + Acarbose
● Blood sugar dilemma :
Fasting blood glucose: 7.2-10.8 mmol/L
Postprandial peak: 14.6-19.3 mmol/L
Intraday fluctuation: >8.4mmol/L
● New plan :
Trelagliptin 100mg/week + Metformin 850mg bid
A high-protein breakfast (3 egg whites + unsweetened yogurt)
Resistance training twice a day
● 12 weeks later :
✓ Fasting blood glucose: 5.8-6.7 mmol/L
✓ Postprandial peak: ≤7.9mmol/L
✓ Intraday fluctuation: <3.1mmol/L
✓ TIR compliance rate: 89% (previously 51%)
06 Three Key Questions and Answers on Precise Blood Sugar Control
❓ How to avoid hypoglycemia with trelagliptin?
The core mechanism is glucose dependence : insulin secretion is stimulated only when blood glucose is >5.6 mmol/L. When blood glucose approaches normal levels (4.4-5.6 mmol/L), the stimulating effect automatically weakens, acting like a built-in "blood glucose fuse" .
❓ Can patients with renal insufficiency use it?
Dosage adjustment required :
● eGFR≥50: 100mg/week
● eGFR 30-50: 50mg/week
● eGFR < 30: Disable
❓ What are its advantages compared to other DPP-4 inhibitors?
The extended half-life (50 hours vs. 12 hours for sitagliptin) brings:
● More sustained DPP-4 inhibition rate (7 days > 70%)
● More stable day-night blood glucose control
The key to a new era of precision blood sugar control
Trelagliptin succinate tablets, with their intelligent on-demand blood sugar lowering mechanism , have completely rewritten the traditional dilemma that "blood sugar control must be accompanied by hypoglycemia or weight gain." When combined with timed protein supplementation, targeted resistance exercise, and dynamic blood glucose monitoring , it constructs a multi-dimensional blood sugar control defense system.
Studies have shown that patients with a glycemic variability (GV) of <36% for 6 consecutive months have a 63% lower risk of microvascular complications.
🏆 Asakusa Cosmetics provides you with
✔️ Authentic Trelagliptin Succinate Tablets
✔️ Hospital prescription
✔️ Online doctor consultation
✔️ Pharmacist's Medication Instructions
✔️ Comprehensive after-sales tracking service
⚠️ Friendly reminder: This article is for reference only. Please consult your doctor for specific medication advice.
---------------------------------------------------------------------------------------------------
📞Welcome to scroll down to contact customer service, purchase online, and have it shipped directly to your door.
🛒Takeda Tragliptin Succinate Tablets, a DPP-4 inhibitor, 50mg in 20 tablets
🛒Takeda Tragliptin Succinate Tablets, a DPP-4 inhibitor, 100mg in 20 tablets